In 2022, Quintanal-Villalonga et al. reported that XPO1 was expressed in SCLC cell lines at levels similar to those observed in relevant hematologic malignancies, and this expression was confirmed in SCLC patient specimens [79]. The gene discussed is XPO1; the disease is small cell lung carcinoma.